Nuvectis Pharma (NVCT) Accumulated Expenses (2021 - 2026)
Nuvectis Pharma (NVCT) recorded Accumulated Expenses of $92,000 in Q2 2026, compared with $2,000 a year earlier and up 155.6% from the prior quarter.
Powered by 
Analysis
Nuvectis Pharma (NVCT) Accumulated Expenses (2021 - 2026) Analysis & Trends
At the end of FY2025, Nuvectis Pharma reported Accumulated Expenses of $115,000, down 86.3% from FY2024.
- Annual Accumulated Expenses has a four-year compound annual growth rate of -26.5% (FY2021 to FY2025).
- Across earlier years, Accumulated Expenses came in at $840,000 in FY2024 (+102.4%), $415,000 in FY2023 (-6.7%), $445,000 in FY2022 (+12.7%) and $395,000 in FY2021.
- Quarterly Accumulated Expenses has ranged from $2,000 in Q2 2025 to $865,000 in Q1 2025 over the past five years.
- On a year-over-year basis, Accumulated Expenses rose in three of the last seven quarters, with an average decline of 14.2%.
- Peak year-over-year performance for Accumulated Expenses in the last five years was growth of 211.5% in Q1 2024, against a decline of 99.4% in Q2 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $36,000 (Q1 2026), $115,000 (Q4 2025) and $65,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Nuvectis Pharma | 563.79 Mn | 563.79 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 92,000.00 |
| Mar 31, 2026 | 36,000.00 |
| Dec 31, 2025 | 115,000.00 |
| Sep 30, 2025 | 65,000.00 |
| Jun 30, 2025 | 2,000.00 |
| Mar 31, 2025 | 865,000.00 |
| Dec 31, 2024 | 840,000.00 |
| Sep 30, 2024 | 282,000.00 |
| Jun 30, 2024 | 310,000.00 |
| Mar 31, 2024 | 486,000.00 |
| Dec 31, 2023 | 415,000.00 |
| Sep 30, 2023 | 158,000.00 |
| Jun 30, 2023 | 571,000.00 |
| Mar 31, 2023 | 156,000.00 |
| Dec 31, 2022 | 445,000.00 |
| Sep 30, 2022 | 738,000.00 |
| Jun 30, 2022 | 790,000.00 |
| Mar 31, 2022 | 697,000.00 |
| Dec 31, 2021 | 395,000.00 |
API Access
Nuvectis Pharma Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=NVCT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "NVCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=NVCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();